SPY305.90+0.35 0.11%
DIA256.42+1.15 0.45%
IXIC9,500.24-51.81 -0.54%

Morgan Stanley Maintains Equal-Weight on Biohaven Pharmaceutical, Raises Price Target to $50

Morgan Stanley maintains Biohaven Pharmaceutical (NYSE:BHVN) with a Equal-Weight and raises the price target from $46 to $50.

Benzinga · 05/11/2020 12:59

Morgan Stanley maintains Biohaven Pharmaceutical (NYSE:BHVN) with a Equal-Weight and raises the price target from $46 to $50.